Marpai, Inc. MRAI
We take great care to ensure that the data presented and summarized in this overview for Marpai, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in MRAI
Top Purchases
Top Sells
About MRAI
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services. It also develops artificial intelligence and healthcare technology that enables the analysis of data to predict and prevent events related to diagnostic errors, hospital visits, and administrative issues. The company was incorporated in 2021 and is headquartered in New York, New York.
Insider Transactions at MRAI
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 20
2025
|
Sagiv Shiv Director |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+25.25%
|
-
|
|
Oct 20
2025
|
Damien Lamendola Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
550,000
+28.95%
|
-
|
|
Oct 20
2025
|
Colleen Di Claudio Director |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+34.48%
|
-
|
|
Oct 20
2025
|
Robert M Pons Director |
BUY
Grant, award, or other acquisition
|
Direct |
225,000
+25.99%
|
-
|
|
Oct 20
2025
|
Steve Andrew Johnson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
275,000
+23.44%
|
-
|
|
Oct 20
2025
|
Jennifer Rosario Calabrese Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+22.22%
|
-
|
|
Oct 20
2025
|
Yaron Eitan Director |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+11.22%
|
-
|
|
Oct 06
2025
|
Intelligent Fanatics Capital Management LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
14,000
-0.78%
|
$14,000
$1.63 P/Share
|
|
Oct 06
2025
|
Intelligent Fanatics Capital Management LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
14,000
-0.78%
|
$14,000
$1.63 P/Share
|
|
Sep 30
2025
|
Damien Lamendola Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
147,058
+2.24%
|
$147,058
$1.36 P/Share
|
|
Sep 10
2025
|
Damien Lamendola Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
896,903
+12.51%
|
$896,903
$1.06 P/Share
|
|
Aug 20
2025
|
Intelligent Fanatics Capital Management LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,000
-0.56%
|
$10,000
$1.42 P/Share
|
|
Aug 20
2025
|
Intelligent Fanatics Capital Management LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.56%
|
$10,000
$1.42 P/Share
|
|
Aug 19
2025
|
Intelligent Fanatics Capital Management LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,000
-1.1%
|
$20,000
$1.4 P/Share
|
|
Aug 19
2025
|
Intelligent Fanatics Capital Management LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-1.1%
|
$20,000
$1.4 P/Share
|
|
Aug 19
2025
|
Jennifer Rosario Calabrese Director |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+37.5%
|
-
|
|
Aug 19
2025
|
Sagiv Shiv Director |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+35.71%
|
-
|
|
Aug 19
2025
|
Yaron Eitan Director |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+4.64%
|
-
|
|
Aug 18
2025
|
Intelligent Fanatics Capital Management LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,000
-1.09%
|
$20,000
$1.4 P/Share
|
|
Aug 18
2025
|
Intelligent Fanatics Capital Management LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-1.09%
|
$20,000
$1.4 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 2.8M shares |
|---|---|
| Open market or private purchase | 1.63M shares |
| Open market or private sale | 188K shares |
|---|